← Leaderboards
Careen K Tang
Georgetown University
$2,470,359
Attributed
$2,470,359
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $502.8K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,470,359 · 2
By mechanism
R01$2,470,359 · 2
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Eric Berens$383,566
- John L. Marshall$2,076,333
- Joyce Marie Slingerland$12,812,016
- Dajun Yang$238,176
- Suzanne C. O'Neill$4,031,510
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineMonoclonal AntibodyInterleukin 3Neoplasm /Cancer ImmunotherapyCell ProliferationEstrogen ReceptorsMetastasisHuman TissueBreast NeoplasmsAntitumor AntibodyEpidermal Growth FactorGrowth Factor ReceptorsImmunocytochemistryCancer TypeCancer TherapyBiological ModelsCancer PatientClinical TrialsCancer Cell LineBaseClassificationCancer CellAnchorage-Independent GrowthChemotherapy
Grant awards (10)
Molecular Mechanisms of Blockage of ErbB receptors$232,510
R01 · FY2009 · CA · contact PI
Molecular Mechanisms of Blockage of ErbB receptors$232,510
R01 · FY2008 · CA · contact PI
Molecular Mechanisms of Blockage of ErbB receptors$232,510
R01 · FY2007 · CA · contact PI
Molecular Mechanisms of Blockage of ErbB receptors$239,453
R01 · FY2006 · CA · contact PI
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer$257,632
R01 · FY2005 · CA
Molecular Mechanisms of Blockage of ErbB receptors$245,216
R01 · FY2005 · CA
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer$257,632
R01 · FY2004 · CA
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer$257,632
R01 · FY2003 · CA
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer$257,632
R01 · FY2002 · CA
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer$257,632
R01 · FY2001 · CA